Acquirer
Gurnet Point Capital
Gurnet Point Capital appears as the named buyer in 3 recorded transactions between 2017 and 2023, most often in healthcare & life sciences.
Gurnet Point Capital is also an investor with a profile here. What it owns, and what it has raised.
Record
What Gurnet Point Capital has bought
Every recorded transaction where Gurnet Point Capital is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Paratek Pharmaceuticals | Healthcare & Life Sciences | — | 2023-06-06 | $462m |
| Corium | Healthcare & Life Sciences | — | 2018-10-11 | $504m |
| Innocoll | Healthcare & Life Sciences | — | 2017-04-04 | $209m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.